445 related articles for article (PubMed ID: 4421343)
1. Keeping prescription drugs safe and effective.
Bryan PA
Am Fam Physician; 1974 Nov; 10(5):189-93. PubMed ID: 4421343
[No Abstract] [Full Text] [Related]
2. Doctors are pivotal to prescription struggle.
Chapman S
Leg Aspects Med Pract; 1979 Mar; 7(3):42-4. PubMed ID: 423688
[No Abstract] [Full Text] [Related]
3. Plugs for drugs.
Masson A; Rubin PH
Regulation; 1986; 10(1):37-43, 53. PubMed ID: 10280556
[No Abstract] [Full Text] [Related]
4. Relative efficacy. When the government decides what drugs should be prescribed, is the patient better served?
Ohio State Med J; 1972 Aug; 68(8):748-52 passim. PubMed ID: 5077306
[No Abstract] [Full Text] [Related]
5. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule.
Fed Regist; 1980 Sep; 45(179 Pt 2):60754-84. PubMed ID: 10248285
[TBL] [Abstract][Full Text] [Related]
6. FDA's regulation of prescription drug labeling: a role for implied preemption.
Kendrick LC
Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
[No Abstract] [Full Text] [Related]
7. New York's generic drug substitution law.
Kamen A
N Y State Dent J; 1980 Nov; 46(9):599-604. PubMed ID: 6935574
[No Abstract] [Full Text] [Related]
8. Knowledge is power: legislative control of drug industry trade secrets.
O'Reilly JT
Spec Law Dig Health Care (Mon); 1987 May; 8(15):7-31. PubMed ID: 10281981
[No Abstract] [Full Text] [Related]
9. Unapproved uses of approved drugs: The physician, the package insert, and the FDA.
Pediatrics; 1978 Aug; 62(2):262-4. PubMed ID: 693165
[No Abstract] [Full Text] [Related]
10. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
Patsner B
Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473
[No Abstract] [Full Text] [Related]
11. Prescriptions enter the political arena.
Regier H
J Leg Med (N Y); 1974; 2(2):24-30. PubMed ID: 4545342
[No Abstract] [Full Text] [Related]
12. Bill may curb physician's right to prescribe.
Harvey MW; Keller SE
Leg Aspects Med Pract; 1978 Sep; 6(9):27-30. PubMed ID: 750818
[No Abstract] [Full Text] [Related]
13. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate.
Dorfman HL; Quinn VM; Brophy EA
Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765
[No Abstract] [Full Text] [Related]
14. The control of drugs and therapeutic freedom.
Dunlop D
Proc R Soc Med; 1968 Aug; 61(8):841-6. PubMed ID: 5695368
[No Abstract] [Full Text] [Related]
15. Therapeutic freedom.
Trout ME
J Leg Med (N Y); 1974; 2(5):40-2. PubMed ID: 4548704
[No Abstract] [Full Text] [Related]
16. Remarks at the Food and Drug Law Institute's 48th Annual Conference.
Niedelman SM
Food Drug Law J; 2005; 60(2):117-26. PubMed ID: 16097089
[No Abstract] [Full Text] [Related]
17. Who really assures prescription drug quality?
J Indiana State Med Assoc; 1979 Mar; 72(3):164. PubMed ID: 422862
[No Abstract] [Full Text] [Related]
18. The case for preemption of prescription drug failure-to-warn claims.
Kim CH
Food Drug Law J; 2007; 62(2):399-422. PubMed ID: 17632969
[No Abstract] [Full Text] [Related]
19. Labeling regulations: 'prescribe as directed'.
Regier H
J Leg Med (N Y); 1974; 2(5):48-51. PubMed ID: 4548706
[No Abstract] [Full Text] [Related]
20. Legalized importation of Canadian prescription drugs: short-term solution to a long-term problem.
Teufel AT
J Contemp Health Law Policy; 2006; 22(2):383-408. PubMed ID: 17117702
[No Abstract] [Full Text] [Related]
[Next] [New Search]
